This is why you shouldn't put make-up on children
An investigation by the Times has found that babies and toddlers are routinely exposed to adult cosmetic products, including fragranced sprays, nail polish and even black henna tattoos.
While these may sound harmless – or even Instagram-friendly – the science tells a more concerning story. Infant skin is biologically different from adult skin: it's thinner, more absorbent and still developing. Exposure to certain products can lead to immediate problems like irritation or allergic reactions, and in some cases, may carry longer term health-risks such as hormone disruption.
This isn't a new concern. A 2019 study found that every two hours in the US, a child was taken to hospital because of accidental exposure to cosmetic products.
Newborn skin has the same number of layers as adult skin but those layers are up to 30% thinner. That thinner barrier makes it easier for substances, including chemicals, to penetrate through to deeper tissues and the bloodstream.
Young skin also has a higher water content and produces less sebum (the natural oil that protects and moisturises the skin). This makes it more prone to water loss, dryness and irritation, particularly when exposed to fragrances or creams not formulated for infants.
The skin's microbiome – its protective layer of beneficial microbes – also takes time to develop. By age three, a child's skin finishes establishing its first microbiome. Before then, products applied to the skin can disrupt this delicate balance. At puberty, the skin's structure and microbiome change again, altering how it responds to products.
The investigation found that bronzers and nail polish were being used on young children. These products often contain harmful or even carcinogenic chemicals, such as formaldehyde, toluene and dibutyl phthalate.
Toluene is a known neurotoxin, and dibutyl phthalate is an endocrine disruptor – a chemical that can interfere with hormone function, potentially affecting growth, development and fertility. Both substances can more easily pass through infants' thinner, more permeable skin.
Even low-level exposure to formaldehyde, such as from furniture or air pollution, has been linked to higher rates of lower respiratory infections in children (that's infections affecting the lungs, airways and windpipe).
Irritating ingredients
In the US, one in three adults experiences skin or respiratory symptoms after exposure to fragranced products. If adults are reacting, it's no surprise that newborns and children with their developing immune systems are at even greater risk.
Perfumes often contain alcohol and volatile compounds that dry out the skin, leading to redness, itching and discomfort.
Certain skincare ingredients have also been studied for their potential to affect hormones, trigger allergies or pose long-term health concerns:
alkylphenols used in detergents and cosmetics may disrupt hormone activity
antimicrobials such as triclosan can interfere with thyroid hormones and contribute to antibiotic resistance
bisphenols, (BPA widely used in packaging are linked to hormone disruption.
cyclosiloxanes (D4 and D5) may accumulate in the body and affect hormonal balance
ethanolamines can react with other ingredients to form nitrosamines, some of which are potential carcinogens
parabens are preservatives that mimic oestrogen, though some studies suggest minimal risk at low doses
phthalates used in fragrances and plastics are linked to reproductive toxicity, especially in early-life exposures
benzophenone is found in many sunscreens and some forms may act as allergens and hormone disruptors.
While many of these ingredients are permitted in regulated concentrations, some researchers warn of a 'cocktail effect': the cumulative impact of daily exposure to multiple chemicals, especially in young, developing bodies.
Temporary tattoos
Temporary tattoos, particularly black henna, are popular on holidays but they aren't always safe. Black henna is a common cause of contact dermatitis in children and may contain para-phenylenediamine (PPD), a chemical approved for use in hair dyes but not for direct application to skin.
PPD exposure can cause severe allergic reactions and, in rare cases, cancer. Children may develop hypopigmentation – pale patches where colour is lost – or, in adults, hyperpigmentation that can last for months or become permanent.
Worryingly, children exposed to PPD may experience more severe reactions later in life if they use hair dyes containing the same compound. This can sometimes lead to hospitalisation or even fatal anaphylaxis. Because of these risks, European legislation prohibits PPD from being applied directly to the skin, eyebrows, or eyelashes.
'Natural' doesn't mean harmless
Products marketed as 'natural' or 'clean' can also cause allergic reactions. Propolis (bee glue), for instance, is found in many natural skincare products but causes contact dermatitis in up to 16% of children.
A study found an average of 4.5 contact allergens per product in 'natural' skincare ranges. Out of 1,651 'natural' personal care products on the US market, only 96 (5.8%) were free from contact allergens. Even claims like 'dermatologically tested' don't guarantee safety; they simply mean the product was tested on skin, not that it's free from allergens.
Babies and young children aren't just miniature adults. Their skin is still developing and is more vulnerable to irritation, chemical absorption and systemic effects: substances that penetrate the skin can enter the bloodstream and potentially affect organs or biological systems throughout the body. Applying adult-targeted products, or even well-meaning 'natural' alternatives, can therefore carry real risks.
Adverse reactions can appear as rashes, scaling or itchiness and, in severe cases, blistering or crusting. Respiratory symptoms like coughing or wheezing should always be investigated by a medical professional.
When in doubt, keep it simple. Limit what goes on your child's skin, especially in the early years.
Adam Taylor is a Professor of Anatomy, Lancaster University
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
AI in Telehealth & Telemedicine Market worth $27.14 Billion by 2030 with 36.4% CAGR
DELRAY BEACH, Fla., July 29, 2025 /PRNewswire/ -- The global AI in Telehealth & Telemedicine Market, valued at US$2.85 billion in 2023 stood at US$4.22 billion in 2024 and is projected to advance at a resilient CAGR of 36.4% from 2024 to 2030, culminating in a forecasted valuation of US$27.14 billion by the end of the period. The market has experienced significant growth primarily driven by the growing geriatric and medically underserved (predominantly rural) population, the increasing prevalence of chronic conditions, the shortage of physicians and care personnel, advancements in telecommunication technologies, and the expansion of RPM systems. However, the growing use of wearables, apps, and sensors for virtual care, the increasing shift towards outpatient care models, and the high utility of telemedicine against infectious diseases and epidemics are significant opportunities in the market. Download PDF Brochure: Browse in-depth TOC on "AI in Telehealth & Telemedicine Market" 409 - Tables58 - Figures380 - Pages By application, the primary care segment commanded the most significant proportion of the AI in telemedicine market due to an increased need for day-to-day healthcare, such as check-ups, chronic condition management, and preventive care, well-suited for AI implementation. These platforms leverage AI to automate symptom evaluation, virtual consultations, and follow-ups to make healthcare more accessible and convenient for day-to-day health issues. Organizations such as Hellocare (US) provide a complete telehealth platform with AI-based solutions for primary care, including virtual patient observation and RPM. These solutions increase patient engagement and simplify care delivery. Furthermore, CVS Health (US) provides CVS Health Virtual Primary Care by providing personalized digital healthcare services, enabling users to access and manage their health remotely. By function, the remote patient monitoring segment is expected to be the fastest-growing segment of AI in telehealth market by function due to the increasing number of chronic diseases (including diabetes, hypertension, and CVDs) that need constant monitoring and management. RPM systems constantly monitor patient health data, eliminating the need for many hospital visits and improving patient outcomes. Many healthcare facilities, such as Mayo Clinic (US), offer RPM systems to reduce readmission rates. In January 2025, Taiwan's Industrial Technology Research Institute (ITRI) introduced AI-based RPM devices that were developed in partnership with StreamTeck (Taiwan) to detect patient vitals (body temperature, heart rate, and blood pressure). By geography, North America accounted for the largest market share due to the region's modern healthcare infrastructure, the widespread use of advanced technologies, and extensive governmental support. The US, especially, has adopted favorable reimbursement policies and regulatory mandates, including those from the Centers for Medicare & Medicaid Services (CMS), to increase telehealth access and RPM technology. Favorable government initiatives have also propelled market growth. In October 2023, the American Telemedicine Association published a new AI principle to advance the safe, appropriate, and responsible use of AI in healthcare that enhances patient and provider trust, safety, and the efficacy of AI adoption as a tool in healthcare. Numerous US-based companies provide AI-based telehealth & telemedicine solutions—in October 2024, Zoom Communications (US) partnered with Suki AI, Inc. (US) to implement AI-powered voice tools within their telehealth services to improve clinical documentation functionalities. Together, these factors enhance North America's leadership in the AI in telehealth & telemedicine market. Request Sample Pages : Prominent players in the telehealth & telemedicine market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), American Well (US), Siemens Healthineers AG (Germany), and Cisco Systems Inc. (US), among others. Koninklijke Philips N.V (Netherlands) Koninklijke Philips N.V. is a diversified technology-based company in the AI in telehealth markets. It is one of the leading companies in the healthcare sector with a strong presence in cardiac care, acute care, and home healthcare. The company operates through four segments: Personal Health, Diagnosis & Treatment, Connected Care, and Others. The AI-based telehealth & telemedicine services fall under the Connected Care segment. The Connected Care segment comprises Business Monitoring, Sleep & Respiratory Care, and Enterprise Informatics. Providers and patients use telehealth solutions. The company operates in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In November 2024, Philips received FDA approval for remote scanning and protocol management features in its Radiology Operations Command Center (ROCC), allowing radiologists to assist with scans remotely. Medtronic (Ireland) Medtronic (Ireland) is one of the largest medical technology, services, and solutions companies. The company operates through four principal segments: Cardiovascular, Diabetes, Medical Surgical, and Neuroscience. The company provides AI-based telemedicine solutions across all four segments. The Cardiac and Vascular segment offers products and services to diagnose, treat, and manage cardiac rhythm disorders and CVDs. Medtronic's portfolio encompasses RPM platforms and patient-centered software through its products and Medtronic Care Management Services. The telehealth solutions offered by the company cover glucose management and cardiac condition management. Medtronic's telehealth device offerings include Bluetooth-enabled and direct-connect peripherals. These devices comprise weight scales, glucometers, blood pressure monitors, pulse oximeters, pedometers, and activity trackers. Medtronic serves its customers in ~160 countries worldwide. The company operates in North America, Latin America, Europe, the Asia Pacific, the Middle East & Africa, and Russia. Epic Systems Corporation (US) Epic Systems Corporation (US) is a software development, installation, and support company that provides consulting services. The company establishes healthcare management software that combines financial and clinical information from inpatient, ambulatory, and payer technology systems. The company's core competency is to provide EHR software solutions. Epic Systems Corporation integrates AI into telehealth & telemedicine through strategic partnerships with Microsoft and Gen AI technologies. Epic improves productivity and patient care in virtual healthcare by combining its EHR solutions with Microsoft's Azure OpenAl Service. It encompasses improving workflows, enabling generative Al to compose message responses, and supporting natural language queries. Epic's AI efforts also enhance self-service reporting tools, maintain financial integrity, and improve clinical outcomes, all of which will enhance global telehealth & telemedicine systems. It operates its offices in the US, the UK, Canada, Denmark, the Netherlands, Norway, Saudi Arabia, the UAE, Finland, Ireland, Australia, Singapore, and Switzerland. For more information, Inquire Now! Related Reports: Telehealth & Telemedicine Market Home Healthcare Market Healthcare IT Market Remote Patient Monitoring (RPM) Market IoT Medical Devices Market Get access to the latest updates on AI in Telehealth & Telemedicine Companies and AI in Telehealth & Telemedicine Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets


CNN
2 hours ago
- CNN
US to burn $9.7 million worth of USAID-purchased contraceptives rather than deliver them to women overseas
The Trump administration is set to destroy $9.7 million worth of US-purchased contraceptives rather than deliver them to women overseas, following the dismantling of foreign assistance programs carried out by the US Agency for International Development, or USAID. The 'preliminary decision' to destroy the USAID-procured birth control was confirmed by a State Department spokesperson, who said the cost of incinerating them would be $167,000. The contraceptives have been housed in a warehouse in Geel, Belgium. The Belgian foreign ministry said it was engaged in diplomatic talks with the US embassy to work to find alternative solutions for the supplies. The contraceptives are mostly long-lasting types of birth control, such as intrauterine devices (IUDs) and injectables, a US congressional aide told CNN. It is not clear exactly when the supplies will be destroyed, according to the aide. 'They have to double incinerate the products because they contain high levels of hormones and they don't want to risk leaking the byproducts out in the environment, which likely adds to the cost,' the congressional aide said. 'The Trump administration is quite literally burning taxpayer money.' A list of the supplies, shared with CNN by another source with knowledge of the warehouse stock, shows that the contraceptives include copper IUDs, rod implants, birth control injections, and levonorgestrel and ethinyl estradiol tablets. Some have USAID branding but the majority do not, according to the source's list. Most of the products expire in 2028 or 2029, with the earliest expiration date among the products in April 2027, according to the list detailing the nearly 5 million items. The US State Department spokesperson referred to the contraceptives to be destroyed as 'certain abortifacient birth control commodities from terminated Biden-era USAID contracts.' There is controversy about whether to describe certain contraceptives as abortifacient, or causing abortion, due to the debate over whether life begins at the moment an egg is fertilized or at a later stage. Some birth control methods, including IUDs, may work by preventing implantation of a fertilized egg. However, IUDs primarily work by suppressing the release of eggs, or by preventing sperm from reaching an egg. CNN has approached the American College of Obstetricians and Gynecologists for comment. 'Only a limited number of commodities have been approved for disposal. No HIV medications or condoms are being destroyed,' the spokesperson added. 'USAID avoided an additional $34.1 million in taxpayer costs by negotiating no-cost cancellations of pending orders placed under the Biden Administration.' Responding to media reports that the contraceptives were set to be transferred to a French medical waste facility to be destroyed by the end of July, a diplomatic source in France told CNN that the contraceptives were being handled by private entities and they had 'no information concerning any transfers,' as of Thursday last week. 'We firmly support the Belgian authorities' commitment to find a solution in order to prevent the destruction of these contraceptives, so that they may reach women and men around the world who need them and are waiting for them,' the diplomatic source added. 'Access to quality sexual and reproductive health services and products is both a human rights and a public health issue.' US Senator Jeanne Shaheen (D-NH) sent a staff member to the warehouse in Belgium as part of her effort to introduce legislation prohibiting 'the destruction of any such commodities unless all efforts to sell or donate them have been exhausted.' The staffer also found that the earliest expiration date for the contraceptives was 2027, with some of the supplies not expiring until 2031, meaning they could still be used for years to come. 'At a moment when the Trump administration has made devastating cuts to foreign assistance it is disappointing that the State Department would sign off on spending money to actually destroy paid-for commodities that would save lives and are waiting to be deployed,' Shaheen said in a statement. 'Food and family planning commodities are desperately needed in conflict affected countries, like Sudan and the Democratic Republic of Congo where famine is taking hold.' Belgian foreign ministry spokeswoman Florinda Baleci told CNN the country was 'exploring all possible avenues to prevent the destruction of these stocks, including their temporary relocation.' An organization called MSI Reproductive Choices said it and other funding partners had offered to pay for the shipping and repackaging of the USAID-branded supplies, but that the US government turned down the offer. 'We were not given a reason for why this offer was not accepted, but it became clear in conversations that it wouldn't be and that our efforts would be better spent finding alternative solutions to the contraception supplies gap,' said Grace Dunne, a spokeswoman for MSI, which works in 36 countries to provide reproductive healthcare, including abortion services, contraception and maternity care. In response to questions about the offer from CNN, the State Department highlighted the so-called 'Mexico City policy,' which 'prohibits providing certain assistance – directly or indirectly – to foreign nongovernmental organizations that perform or actively promote abortion as a method of family planning.' That policy, which opponents call the 'global gag rule,' prevents non-governmental organizations that provide abortions, give counseling about abortions or advocate for safe access to abortion from receiving US funding. The planned destruction of the contraceptives has sparked an outcry from other organizations, like Doctors Without Border (MSF), which raised concerns about contraceptive shortages in nations that were once reliant on supplies donated by USAID. 'In the communities served by MSF – whether impacted by conflict, disease outbreaks, natural and human-made disasters, or exclusion from health care – access to contraceptives is already constrained,' the organization said in a statement. 'Contexts that previously relied upon USAID funded contraceptive supplies are at a heightened risk of supply chain disruptions and stockouts.' 'MSF has seen firsthand the positive health benefits when women and girls can freely make their own health decisions by choosing to prevent or delay pregnancy – and the dangerous consequences when they cannot,' the chief executive of MSF USA, Avril Benoît, added. MSF also cited reports saying that more USAID-branded contraceptives are being housed in a warehouse in the United Arab Emirates, but the organization said the US government's plan for those supplies is unknown. A State Department spokesperson did not address a question about contraceptives warehoused in the UAE. CNN has reached out to the UAE government for comment. At the beginning of July, US Secretary of State Marco Rubio hailed the end of USAID, saying that future foreign assistance programs would align with administration policies and be administered by the State Department. The rapid dismantling of USAID, led by the Department of Government Efficiency (DOGE), has seen thousands of foreign assistance programs slashed, including many that focused on lifesaving work. A study published earlier this month by a leading medical journal, The Lancet, estimated that the USAID funding cuts could result in more than 14 million additional deaths by 2030. USAID funding was most likely to reduce mortality related to HIV/AIDS, followed by malaria, according to the study.


New York Times
5 hours ago
- New York Times
UnitedHealth's Profits Fall as Costs of Care Continue to Rise
UnitedHealth Group, the giant health care conglomerate, said on Tuesday that it continued to struggle with higher-than-anticipated costs of providing medical care to patients enrolled in its health plans, reporting a drop in earnings for the quarter ended June 30. While UnitedHealth remained profitable, its operating earnings for the three months fell to $5.2 billion from $7.9 billion in the same period of 2024. Revenues, however, increased to $111.6 billion for the three months of 2025, compared with $98.9 billion for the same period of 2024. The higher costs were felt across the company's vast health insurance operations, including one of its most successful businesses, selling private Medicare plans as an alternative to traditional Medicare. UnitedHealth owns the nation's largest health insurer, UnitedHealthcare, which covers 50 million people. Other insurance companies have also reported rising medical costs and disappointing profits. Last Friday, Centene, a for-profit insurance company that focuses mostly on patients who are enrolled in Medicaid and Obamacare plans, was the latest insurer to blame rising expenses for poor financial results. But UnitedHealth's stumble, which began earlier this year, has shocked many of its investors who have come to rely on steady increases of profits from the conglomerate. Since November, the company's stock has lost roughly half of its value. The company owns an assortment of health care businesses, including surgery centers, a vast network of medical practices, and a big pharmacy benefit manager as well as health insurance plans. In the new earnings report, UnitedHealth acknowledged that many of the businesses housed under its Optum unit were also underperforming, including its network of physicians and other clinicians who provide care under the privatized portion of the Medicare program, known as Medicare Advantage. UnitedHealth has experienced a series of misfortunes over the last two years, including the murder of the chief executive of its insurance operations, Brian Thompson. Investors have lost confidence in the company's business model, and patients have grown increasingly frustrated with its methods. In May, it abruptly replaced its chief executive, Andrew Witty, with Stephen Hemsley, who had stepped down from the position in 2017. Last week, the company confirmed the Department of Justice was investigating its Medicare operations. UnitedHealth announced its earnings before the stock market opened. Mr. Hemsley took steps to reassure investors. The company, which had withdrawn its profit outlook for the year, provided investors with an estimate of what it expected to earn for 2025. It estimated revenues of slightly under $450 billion with net earnings of at least $14.65 per share. The company said it expected to return to earnings growth in 2026. 'UnitedHealth Group has embarked on a rigorous path back to being a high-performing company fully serving the health needs of individuals and society broadly,' Mr. Hemsley said in a statement in the company's earnings release. 'As we strengthen operating disciplines, positioning us for growth in 2026 and beyond, the people at UnitedHealth Group will continue to support the millions of patients, physicians and customers who rely on us, guided by a culture of service and longstanding values.'